Misoprostol for termination of pregnancy with intrauterine fetal demise in the second and third trimester of pregnancy - a systematic review

Contraception

Volumn 79, Issue 4, 2009, Pages 259-271

  Gómez Ponce de León, Rodolfo ^a   Wing, Deborah A ^b  

^a IL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Fetal demise; Misoprostol; Pregnancy termination

Indexed keywords

GEMEPROST; MISOPROSTOL; NITRIC OXIDE DONOR; OXYTOCIN; PLACEBO; PROSTAGLANDIN; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA;

ABDOMINAL PAIN; BALLOON CATHETER; CHILL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DELIVERY; DIARRHEA; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG SAFETY; EFFECT SIZE; FEMALE; FETUS DEATH; FEVER; HEADACHE; HUMAN; LABOR INDUCTION; LAMINARIA; META ANALYSIS; NAUSEA; OUTCOME ASSESSMENT; PREGNANCY TERMINATION; RANDOMIZED CONTROLLED TRIAL; REVIEW; SAMPLE SIZE; SECOND TRIMESTER PREGNANCY; SYSTEMATIC REVIEW; THIRD TRIMESTER PREGNANCY; UTERINE CERVIX RIPENING; UTERUS RUPTURE; VOMITING;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ADMINISTRATION, INTRAVAGINAL; ADMINISTRATION, ORAL; ADMINISTRATION, SUBLINGUAL; FEMALE; FETAL DEATH; HUMANS; MISOPROSTOL; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD;

EID: 61449150383     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2008.10.009     Document Type: Review

References (52)

1. Eng N.S., and Guan A.C. Comparative study of intravaginal misoprostol with gemeprost as an abortifacient in second trimester missed abortion. Aust N Z J Obstet Gynaecol 37 (1997) 331-334
2. Weiner C.P. Fetal death. In: James D.K., Steer P.J., Weiner C.P., and Gonik B. (Eds). High risk pregnancy management options. 2nd ed. (1999), WB Saunders, London 323-326
3. Winikoff B., Ellerston C., and Clark S. Analysis of failure in medical abortion. Contraception 54 (1996) 323-327
4. Grimes D.A. Medical abortion in early pregnancy: a review of the evidence. Obstet Gynecol 89 (1997) 790-796
5. Slade P., Heke S., Fletcher J., and Stewart P. A comparison of medical and surgical termination of pregnancy: choice, emotional impact and satisfaction with care. Br J Obstet Gynaecol 105 (1998) 1288-1295
6. Costa S.H., and Vessey M.P. Misoprostol and illegal abortion in Rio de Janeiro, Brazil. Lancet 342 (1993) 1258-1261
7. Senior J., Marshall K., Sangha R., and Clayton J.K. In vitro characterization of prostanoid receptors on human myometrium at term pregnancy. Br J Pharmacol. 108 2 (1993 Feb) 501-506
8. Zieman M., Frong S.K., Benowitz N.L., Banskter D., and Darney P.D. Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol 90 (1997) 88-92
9. Tang O.S., Schweer H., Seyberth H.W., Lee S.W., and Ho P.C. Pharmacokinetics of different routes of administration of misoprostol. Human Reprod 17 (2002) 332-336
10. Tang O.S., Gemzell Danielsson K., and Ho P.C. Misoprostol: Pharmacokinetic profiles, effects on the uterus and side effects. Int J Gynaecol Obstet. 99 (2007) 160-167
11. In: Royal College of Obstetricians and Gynaecologists (Ed). Medical methods of abortion. The care of women requesting induced abortion. Evidence-Based Clinical Guideline Number 7 (2004), RCOG Press, London 52-56
12. Gomez Ponce de Leon R., Wing D., and Fiala C. Misoprostol for intrauterine fetal death. Int J Gynaecol Obstet 99 (2007) 190-193
13. Henry A.M., and Haukkamaa M. Comparison of vaginal misoprostol and gemeprost as pre-treatment in first trimester pregnancy interruption. Br J Obstet Gynaecol 106 (1999) 540-543
14. Dickinson J.E., Godfrey M., and Evans S.F. Efficacy of intravaginal misoprostol in second-trimester pregnancy termination: a randomized controlled trial. J Matern Fetal Med 7 (1998) 115-119
15. Bamigboye A.A., Merrell D.A., Hofmeyr G.J., and Mitchell R. Randomized comparison of rectal misoprostol with Syntometrine for management of third stage of labor. Acta Obstet Gynecol Scand 77 (1998) 178-181
16. Diab K.M., Ramy A.R., and Yehia M.A. The use of rectal misoprostol as active pharmacological management of the third stage of labor. J Obstet Gynaecol Res 25 (1999) 327-332
17. Dodd J., Crowther C.A., Dodd J.M., and Crowther C.A. Misoprostol for induction of labour to terminate pregnancy in the second or third trimester for women with a fetal anomaly or after intrauterine fetal death. Cochrane Database Syst Rev 3 (2004) CD004901 10.1002/14651858.CD004901
18. Dodd J.M., and Crowther C.A. Misoprostol versus cervagem for the induction of labour to terminate pregnancy in the second and third trimester: a systematic review. Eur J Obstet Gynecol Reprod Biol 125 (2006) 3-8
19. Hofmeyr G.J., and Gulmezoglu A.M. Vaginal misoprostol for cervical ripening and induction of labour. Cochrane Database Syst Rev 1 (2003) CD000941 [Review]
20. Danielsson K.G., Marions L., Rodriguez A., Spur B.W., Wong P.Y., and Bygdeman M. Comparison between oral and vaginal administration of misoprostol on uterine contractility. Obstet Gynecol 93 (1999) 275-280
21. Meckstroth K.R., Whitaker A.K., Bertisch S., Goldberg A.B., and Darney P.D. Misoprostol administered by epithelial routes: Drug absorption and uterine response. Obstet Gynecol. 108 3 Pt 1 (2006) 582-590
22. In: Higgins J.P.T., and Green S. (Eds). Cochrane handbook for systematic reviews of interventions (2008). Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008 www.cochrane-handbook.org
23. Bebbington M.W., Kent N., Lim K., et al. A randomized controlled trial comparing two protocols for the use of misoprostol in midtrimester pregnancy termination. Am J Obstet Gynecol 187 (2002) 853-857
24. Bugalho A., Bique C., Machungo F., and Faundes A. Induction of labor with intravaginal misoprostol in intrauterine fetal death. Am J Obstet Gynecol 171 2 (1994) 538-541
25. Bugalho A., Bique C., Machungo F., and Bergstrom S. Vaginal misoprostol as an alternative to oxytocin for induction of labor in women with late fetal death. Acta Obstet Gynecol Scand 74 (1995) 194-195
26. Cohen Blumenthal F., and Medina C. Use of misoprostol for induction of second-trimester abortion in patients with previous cesarean delivery. Obstet Gynecol 97 4 Suppl (2001) 68S
27. de Heus R., Graziosi G.C.M., Christiaens G.C.M.L., Bruinse H.W., and Mol B.W.J. Medical management for termination of second and third trimester pregnancies: a comparison of strategies. Eur J Obstet Gynecol Reprod Biol 116 (2004) 16-21
28. Dickinson J.E. Misoprostol for second-trimester pregnancy termination in women with a prior cesarean delivery. Obstet Gynecol 105 2 (2005) 352-356
29. Feldman D.M., Borgida A.F., Rodis J.F., Leo M.V., and Campbell W.A. A randomized comparison of two regimens of misoprostol for second-trimester pregnancy termination. Am J Obstet Gynecol 189 (2003) 710-713
30. Gonzalez J.A., Carlan S.J., and Alverson M.W. Outpatient second trimester pregnancy termination. Contraception 63 (2001) 89-93
31. Jain J.K., Kuo J., and Mishell D.R. A comparison of two dosing regimens of intravaginal misoprostol for second-trimester pregnancy termination. Obstet Gynecol 93 (1999) 571-575
32. Leader J., Bujnovsky M., Carlan S.J., Triana T., and Richichi K. Effect of oral misoprostol after second-trimester delivery: a randomized, blinded study. Obstet Gynecol 100 (2002) 689-694
33. Li C.F., Chan C.W., and Ho P.C. A study of the efficacy of cervical ripening with nitric oxide donor versus placebo for cervical priming before second-trimester termination of pregnancy. Contraception 68 (2003) 269-272
34. Menakaya U., Otoide V., Omo Agboja L., Odunsi K., and Okonofua F. Experience with misoprostol in the management of missed abortion in the second trimester. J Obstet Gynaecol 25 6 (2005) 583-585
35. Munthali J., and Moodley J. The use of misoprostol for mid-trimester therapeutic termination of pregnancy. Trop Doct 31 (2001) 157-160
36. Nuthalapaty F.S., Ramsey P.S., Biggio J.R., and Owen J. High-dose vaginal misoprostol versus concentrated oxytocin plus low-dose vaginal misoprostol for midtrimester labor induction: a randomized trial. Am J Obstet Gynecol 193 (2005) 1065-1070
37. Owen J., and Hauth J.C. Vaginal misoprostol versus concentrated oxytocin plus low-dose prostaglandin E2 for second trimester pregnancy termination. J Matern Fetal Med 8 (1999) 48-50
38. Ramsey P.S., Savage K., Lincoln T., and Owen J. Vaginal misoprostol versus concentrated oxytocin and vaginal PGE2 for second-trimester labor induction. Obstet Gynecol 104 (2004) 138-145
39. Yapar E.G., Senöz S., Ürkütür M., Batioglu S., and Gökmen O. Second trimester pregnancy termination including fetal death: comparison of five different methods. Eur J Obstet Reprod Biol 69 (1996) 97-102
40. Caliskan E., Dilbaz S., Doger E., Ozeren S., and Dilbaz B. Randomized comparison of 3 misoprostol protocols for abortion induction at 13-20 weeks of gestation. J Reprod Med 50 3 (2005) 173-180
41. Chittacharoen A., Herabutya Y., and Punyavachira P. A randomized trial of oral and vaginal misoprostol to manage delivery in cases of fetal death. Obstet Gynecol 101 (2003) 70-73
42. Fadalla F.A., Mirghani O.A., and Adam I. Oral misoprostol versus vaginal misoprostol for termination of pregnancy with intrauterine fetal demise in the second-trimester. Int J Gynaecol Obstet 86 (2004) 52-53
43. Ghorab M.N.M., and El Helw B.A. Second-trimester termination of pregnancy by extra-amniotic prostaglandin F2 alfa or endocervical misoprostol. Acta Obstet Gynecol Scand 77 (1998) 429-432
44. Hidar S., Fekih M., Chaieb A., Bibi M., Mellouli R., and Khairi H. Apport de l'association d'ocytocine au misoprostol administré en intravaginal au cours des interruptions de grossesses entre 13 et 29 semaines d'aménorrhée. Essai clinique prospectif randomisé. J Gynecol Obstet Biol Reprod 30 (2001) 439-443
45. Jain J.K., and Mishell Jr. D.R. A comparison of intravaginal misoprostol with prostaglandin E2 for termination of second-trimester pregnancy. N Engl J Med 331 (1994) 290-293
46. Jain J.J., and Mishell D.R. A comparison of misoprostol with and without laminaria tents for induction of second-trimester abortion. Am J Obstet Gynecol 175 (1996) 173-177
47. Makhlouf A.M., Al-Hussaini T.K., Habib D.M., and Makarem M.H. Second-trimester pregnancy termination: comparison of three different methods. J Obstet Gynecol 23 4 (2003) 407-411
48. Nakintu N. A comparative study of vaginal misoprostol and intravenous oxytocin for induction of labour in women with intra uterine fetal death in Mulago Hospital, Uganda. Afr Health Sci 1 (2001) 55-59
49. Niromanesh S., Hashemi-Fesharaki M., and Mosavi-Jarrahi A. Second trimester abortion using intravaginal misoprostol. Int J Gynaecol Obstet 89 (2005) 276-277
50. Nyende L., Towobola O.A., and Mabina M.H. Comparison of vaginal and oral misoprostol, for the induction of labour in women with intra-uterine foetal death. East Afri Med J 81 (2004) 179-182
51. Yilmaz B., Kelekci S., Ertas I.E., Kahyaoglu S., Ozel M., Sut N., et al. Misoprostol moistened with acetic acid or saline for second trimester pregnancy termination: a randomized prospective double-blind trial. Hum Reprod 20 11 (2005) 3067-3071
52. Yilmaz B., Kelekci S., Ertas I.F., et al. Randomized comparison of second trimester pregnancy termination utilizing saline moistened or dry misoprostol. Arch Gynecol Obstet 276 (2007) 511-516